黑色真菌茎在印度共同19岁的患者

[新德里]印度数百名Covid-19患者中出现了一种称为粘膜细胞增多的真菌疾病，这给已经在破裂点上的医院带来了进一步的压力。

这US Centers for Disease Control and Prevention (CDC)saidthat mucormycosis, also known as black fungus, is a “serious but rare” infection caused by a group of moulds called mucormycetes. It usually affects the sinuses or lungs after fungal spores are inhaled from the air but can also occur on the skin after a cut or burn.

这Indian government has not yet announced the number of mucormycosis cases among patients withCOVID-19，，，，butmedia报告说,are more than 400 victims in古吉拉特邦，，，，200 inMaharashtra以及德里，班加罗尔和海得拉巴城市的医院中的其他一些人。

Diptendra Sarkar, a COVID-19 strategist, public health analyst and professor at theInstitute of Post Graduate Medical Education and Research，，，，Kolkata, India, tellsscidev.netthat extensive use of immunosuppressantdrugsfor the treatment of COVID-19 may be responsible for the rising incidence.

“This is more common amongst diabetics, transplant patients, prolonged high-dose steroid recipients and patients on cancer chemotherapy,” Sarkar explains. “Though the incidence is sporadic, busy ICUs [intensive care units] can become epicentres for the surge in [mucormycosis] cases and create a huge challenge tohealthresources.”

根据Raghuraj Hegde，顾问眼科医生Manipal Hospital，，，，in Bengaluru, India, the virulence of the new strain of COVID-19 virus causes patients’ blood sugars to shoot up, which in turn provides a suitable environment for mucormycosis. “The steroids used in COVID-19 treatment possibly add fuel to the fire already raging,” he tellsscidev.net。

“ Covid-19治疗中使用的类固醇可能为火灾已经肆虐的燃料增加了燃料”

拉古拉·黑格（Raghuraj Hegde），马尼帕尔医院

In a recent陈述，，，，Vinod Paul, a member of the government think tank the国家转型印度机构（Niti Aayog），，，，says there is no major outbreak of mucormycosis in the country. However, reports from the states present a grimmer picture.

5月8日，tweet古吉拉特邦首席部长办公室说，州政府已决定在艾哈迈达巴德，瓦多达拉，苏拉特，拉杰科特，巴夫纳加尔和贾姆纳加尔的民事医院开设单独的粘膜病患者病房。

这governmenthas also ordered 5,000 injections of the antifungal drug amphotericin B to treat mucormycosis, according to the tweet.

古吉拉特邦Govt, under CM Shri@vijayrupanibjp的方向，决定在艾哈迈达巴德 - 瓦多达拉 - - 苏拉特拉族 - 拉杰科特 - 巴哈夫纳加尔 - 贾姆纳加尔民用医院和5000个两性两性霉素B 50毫克注射量的命令中，为粘膜细胞增多患者开设单独的病房，以治疗5000 r.3.12-CR，用于治疗粘液cosisosis Mucormycisosis b。pic.twitter.com/zyfwp9y070

- CMO Gujarat（@CMOGUJ）2021年5月8日

5月10日，马哈拉施特拉邦政府宣布free treatment for mucormycosis for everyone in the state, under a government-run health insurance scheme.

阿克沙伊·奈尔（Akshay Nair），眼镜外科医生Aditya JyotandAgarwals博士孟买的眼科医院，，，，says the increase in mucormycosis cases is alarming because the healthcare system is already overburdened with COVID-19 cases. The additional burden of patients requiring urgent diagnosis and care due to mucormycosis adds further pressure on the healthcare system, he tellsscidev.net。

根据Nair, mucormycosis was an extremely rare condition and the availability of amphotericin B was adequate. “Now, a sudden increase in the utilisation of this drug has depleted available stocks leading to shortages,” he explains.

“州政府应确保两性霉素B的足够生产，储存和交付，并采取严格的行政措施，以停止ho积和黑人销售药物，”Shantanu Panja，顾问Ent外科医生阿波罗·格莱纳格尔斯医院in Kolkata, tellsscidev.net。

这件作品由Scidev.net的亚太桌子制作。